Indaba Capital Management

Latest statistics and disclosures from Indaba Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Indaba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Indaba Capital Management

Indaba Capital Management holds 9 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Standard Biotools Note 5.250%12/0 (Principal) 24.9 $43M 41M 1.07
 View chart
Bandwidth Note 0.500% 4/0 (Principal) 19.2 $34M 53M 0.64
 View chart
On24 (ONTF) 19.2 $33M 4.2M 7.88
 View chart
Snap One Holdings Corp (SNPO) 15.9 $28M 3.1M 8.91
 View chart
D Fluidigm Corp Del (LAB) 9.4 $17M 7.4M 2.21
 View chart
Accelerate Diagnostics Note 5.000%12/1 (Principal) 8.6 $15M NEW 23M 0.64
 View chart
Merrimack Pharmaceuticals In Com New (MACK) 1.7 $3.0M +63% 224k 13.41
 View chart
Owl Rock Capital Corporation (OBDC) 0.8 $1.4M -65% 93k 14.76
 View chart
Holley *w Exp 11/30/202 (HLLY.WS) 0.2 $368k 669k 0.55
 View chart

Past Filings by Indaba Capital Management

SEC 13F filings are viewable for Indaba Capital Management going back to 2013

View all past filings